Showa Denko (SDK) (TOKYO: 4004) decided at its Board of Directors meeting on changes in corporate management (directors, audit & supervisory board members, corporate officers, executive officers, and councilors). SDK will organize a new management team integrated with that of Showa Denko Materials Co., Ltd. (SDMC), aiming to accelerate integration of organizations of SDK and SDMC and promote speedy management of the Showa Denko Group.
In addition, SDK will establish a new position named 'Executive Officer' as a position between Corporate Officer and Councilor, effective January 4, 2022. Motohiro Takeuchi (Representative Director; Managing Corporate Officer; Chief Financial Officer (CFO); officer in charge of Finance & Accounting, and Information Systems departments) will resign as Representative Director and Managing Corporate Officer on January 3, 2022. He will assume the post of Assistant to President on January 4, 2022. He will also resign as Director at the General Meeting of Shareholders in late March 2022.
Hideo Ichikawa (Director; Chairman of the Board) will resign as Director at the General Meeting of Shareholders in late March 2022 and become Executive Advisor. Hideki Somemiya (General Manager, Preparation Office for Group CFO) and Tomomitsu Maoka (General Manager, Preparation Office for Group CSO) will be elected directors of SDK at the General Meeting of Shareholders in late March 2022. Prior to these promotions, Somemiya will become Managing Corporate Officer; Chief Financial Officer (CFO), and Maoka will become Managing Corporate Officer; Chief Strategy Officer (CSO), both effective January 4, 2022.
Setsu Onishi will resign as Outside Member of the Audit & Supervisory Board at the General Meeting of Shareholders in late March 2022. Meanwhile, Yasuyuki Miyasaka (Yasuyuki Miyasaka CPA Office; Outside Member of the Audit & Supervisory Board, ITOCHU-SHOKUHIN Co., Ltd.; Outside Corporate Auditor, Board of Corporate Auditors, Santen Pharmaceutical Co., Ltd.) will be elected as Outside Member of the Audit & Supervisory Board at the General Meeting of Shareholders in late March 2022.
Kohei Morikawa will resign as Corporate Officer, President and CEO on January 3, 2022. He will become Representative Director, Chairman of the Board on January 4.
Jiro Ishikawa (Senior Managing Corporate Officer; General Manager, Device Solutions Division; officer in charge of Electronics Materials Project and Chichibu Plant) will resign as Senior Managing Corporate Officer on January 3, 2022. He will become Executive Officer; General Manager, Device Solutions Division on January 4, 2022. Yoichi Takeuchi (Corporate Officer; Plant Manager, Kawasaki Plant) will resign as Corporate Officer on January 3, 2022. He will become Corporate Expert, Assistant to President on January 4, 2022.
Resonac Holding Corporation (formerly Showa Denko KK) is a holding company organized around 7 family of products:
- materials (43.8% of net sales): electronics materials (epoxy molding compounds, die bonding materials, CMP slurries, anisotropic conductive films), printed wiring board materials (copper-clad laminates, photosensitive dry films), mobility components (plastic molded products, friction materials, powder metal products, carbon anode materials for LIBs), energy storage devices and systems (automotive and industrial batteries), and life sciences (diagnostics, contracted manufacturing of regenerative medicine products);
- petrochemical products (19.6%): olefins (polyethylene, polypropylene) and organic chemical products (vinyl acetate monomer, ethyl acetate and plastics);
- chemical products (12.9%): caustic soda, chlorine, liquid ammonia, amino acids, polymers, gas (oxygen, nitrogen, hydrogen), etc.;
- electronic components (8.3%): hard disks, semiconductors components, magnetic components, etc.;
- inorganic products (7.1%): ceramics and carbons (graphite electrodes);
- aluminum products (5.3%): aluminum foils, extruded products, forged products, cans, etc.;
- other (3%).
Net sales break down geographically as follows: Japan (53.4%), China (12%), Asia (20.6%) and other (14%).